CECCHETTI, Violetta
 Distribuzione geografica
Continente #
NA - Nord America 6.695
EU - Europa 5.258
AS - Asia 4.508
SA - Sud America 600
AF - Africa 73
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.156
Nazione #
US - Stati Uniti d'America 6.589
SG - Singapore 1.826
IT - Italia 1.008
UA - Ucraina 892
IE - Irlanda 869
CN - Cina 774
HK - Hong Kong 686
SE - Svezia 659
VN - Vietnam 637
RU - Federazione Russa 546
BR - Brasile 521
DE - Germania 351
FI - Finlandia 263
KR - Corea 196
GB - Regno Unito 169
BE - Belgio 112
TR - Turchia 78
JP - Giappone 71
FR - Francia 69
PL - Polonia 68
IN - India 55
CA - Canada 50
RO - Romania 44
MX - Messico 43
NL - Olanda 41
CH - Svizzera 37
AR - Argentina 33
UZ - Uzbekistan 31
BD - Bangladesh 29
ZA - Sudafrica 28
AT - Austria 27
ES - Italia 27
CZ - Repubblica Ceca 26
ID - Indonesia 18
IQ - Iraq 17
EC - Ecuador 13
PK - Pakistan 13
CI - Costa d'Avorio 11
LB - Libano 11
AU - Australia 10
MA - Marocco 10
EG - Egitto 9
LT - Lituania 9
DK - Danimarca 7
EU - Europa 7
GR - Grecia 7
IL - Israele 7
IR - Iran 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
CL - Cile 6
SA - Arabia Saudita 6
CO - Colombia 5
KE - Kenya 5
MY - Malesia 5
UY - Uruguay 5
KZ - Kazakistan 4
PA - Panama 4
PE - Perù 4
PY - Paraguay 4
VE - Venezuela 4
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TM - Turkmenistan 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CM - Camerun 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
Totale 17.148
Città #
Singapore 1.215
Chandler 1.091
Dublin 869
Hong Kong 673
Dong Ket 487
Jacksonville 480
Perugia 463
San Mateo 460
Ashburn 351
Boardman 307
Santa Clara 256
Medford 205
Princeton 203
Seoul 193
Beijing 183
Ann Arbor 167
Wilmington 159
Altamura 146
Andover 128
Lawrence 123
Moscow 118
Brussels 112
Los Angeles 111
Munich 99
New York 89
Piscataway 76
Fremont 75
Ho Chi Minh City 67
Des Moines 65
Tokyo 64
The Dalles 62
Saint Petersburg 57
Turku 54
São Paulo 49
West Jordan 48
Warsaw 45
Izmir 44
Nanjing 43
Redmond 43
Norwalk 39
Dearborn 36
Brooklyn 35
Woodbridge 35
Dallas 34
Atlanta 29
Denver 28
Hanoi 28
Helsinki 28
Rome 28
Falls Church 27
Bucharest 25
Spoleto 25
Columbus 24
Hefei 24
Poplar 23
San Giustino 23
Chicago 22
San Paolo di Civitate 22
Montreal 21
Redwood City 21
Stockholm 21
Houston 20
Shanghai 19
Chennai 18
Orem 18
London 17
San Diego 17
San Francisco 17
Seattle 17
Ankara 16
Den Haag 16
Phoenix 16
Philadelphia 15
Rio de Janeiro 15
Auburn Hills 14
Boston 14
Charlotte 14
Chongqing 14
Johannesburg 14
Secaucus 14
Hanover 13
Manchester 13
Olomouc 13
Council Bluffs 12
Curitiba 12
Guangzhou 12
Abidjan 11
Bologna 11
Mexico City 11
Porto Alegre 11
San Jose 11
Tashkent 11
Timisoara 11
Recife 10
Amsterdam 9
Belo Horizonte 9
Brasília 9
Dhaka 9
Lappeenranta 9
Milan 9
Totale 10.599
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 305
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 298
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 287
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 285
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 229
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 171
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 154
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 151
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 144
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 137
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 137
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 128
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 125
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 124
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 123
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 121
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 116
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 116
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 114
New Insights on KCa3.1 Channel Modulation 112
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 111
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 111
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 110
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 109
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 109
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 108
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 107
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 107
6-Aminoquinolones as New Potential Anti-HIV Agents 106
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 106
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 106
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 105
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 105
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 104
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 104
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 104
6-Desfluoroquinolones as promising HIV transcription inhibitors 103
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 103
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 103
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 100
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 100
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 99
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 99
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 98
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 98
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 97
A New Derivative with Ultra-Potent Anti-HIV Activity 97
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 97
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 96
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 96
A new 6-aminoquinolone compound with anti-HCMV activity 95
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 95
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 95
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 95
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 94
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 94
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 93
The antibacterial activity of quinolones against E.coli: a chemometric study 93
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 93
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 93
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 93
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 93
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 91
QSAR study and VolSurf characterization of anti-HIV quinolone library 91
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 91
S. aureus NorA efflux pump: the discovery of new potent inhibitors 90
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 90
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 89
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 89
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 89
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 89
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 87
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 87
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 87
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 87
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 87
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 86
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 86
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 86
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 85
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 85
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 85
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 85
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 84
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 84
In Vitro Activities of New Quinolones Against Helicobacter pylori 83
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 83
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 83
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 83
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 83
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 83
One-Pot Synthesis of Rufloxacin 82
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 82
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 82
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 82
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 82
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 81
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 81
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 81
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 80
Totale 10.842
Categoria #
all - tutte 78.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.346 0 0 0 0 0 152 209 14 233 68 147 523
2021/20222.004 58 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.419 51 287 122 298 403 167 289 194 591 199 545 273
2025/20263.399 497 452 341 884 923 302 0 0 0 0 0 0
Totale 17.746